Covered recipient · General Payments record
SHAHAN V YACOUBIAN
Allopathic & Osteopathic Physicians Orthopaedic Surgery Adult Reconstructive Orthopaedic Surgery
General Payments · PY2018–2024
$214,400.29
- Reported across 231 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Royalty or License | $12,405.36 | 3 |
| Consulting Fee | $6,037.50 | 6 |
| Food and Beverage | $237.12 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ENCORE MEDICAL, LP | $18,155.36 | 8 |
| Insight Medical Systems, Inc. | $287.50 | 1 |
| Think Surgical, Inc. | $129.88 | 1 |
| Stryker Corporation | $36.58 | 1 |
| Smith & Nephew, Inc. | $26.48 | 1 |
| Mylan Specialty L.P. | $25.73 | 1 |
| Medtronic, Inc. | $18.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ENCORE MEDICAL, LP | $575.00 | 01/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1154727565 | CMS |
| ENCORE MEDICAL, LP | $5,304.78 | 01/30/2024 | Royalty or License | Undisputed | 01/23/2026 | 1154727643 | CMS |
| ENCORE MEDICAL, LP | $1,725.00 | 03/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1154727567 | CMS |
| ENCORE MEDICAL, LP | $3,796.52 | 04/26/2024 | Royalty or License | Undisputed | 01/23/2026 | 1154727645 | CMS |
| ENCORE MEDICAL, LP | $1,725.00 | 06/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1154727579 | CMS |
| ENCORE MEDICAL, LP | $575.00 | 06/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1154727609 | CMS |
| ENCORE MEDICAL, LP | $1,150.00 | 09/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1154727601 | CMS |
| ENCORE MEDICAL, LP | $3,304.06 | 10/30/2024 | Royalty or License | Undisputed | 01/23/2026 | 1154727647 | CMS |
| Insight Medical Systems, Inc. | $287.50 | 06/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1154730607 | CMS |
| Medtronic, Inc. | $18.45 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119373280 | CMS |
| Mylan Specialty L.P. | $25.73 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147302600 | CMS |
| Smith+Nephew, Inc. | $26.48 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149478939 | CMS |
| Stryker Corporation | $36.58 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120020465 | CMS |
| Think Surgical, Inc. | $129.88 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138639319 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.